| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute presentation of autoimmune hepatitis –from acute hepatitis to ALF and ACLF-
|
Tanaka, Atsushi
|
|
|
18 |
5 |
p. 1385-1395
|
artikel
|
| 2 |
APASL Oncology 2024 Chiba
|
|
|
|
18 |
5 |
p. 1592-1660
|
artikel
|
| 3 |
CBX1 is involved in hepatocellular carcinoma progression and resistance to sorafenib and lenvatinib via IGF-1R/AKT/SNAIL signaling pathway
|
Zheng, Su-Su
|
|
|
18 |
5 |
p. 1499-1515
|
artikel
|
| 4 |
“Cherry blossom” in Kyoto brought hope to patients with chronic hepatitis B infection
|
Chen, Jing
|
|
|
18 |
5 |
p. 1431-1433
|
artikel
|
| 5 |
Clinical significance of circulating biomarkers of immune-checkpoint molecules with atezolizumab plus bevacizumab therapy in unresectable hepatocellular carcinoma
|
Chuma, Makoto
|
|
|
18 |
5 |
p. 1472-1485
|
artikel
|
| 6 |
Diagnosis and management of pediatric acute liver failure: consensus recommendations of the Indian Society of Pediatric Gastroenterology, Hepatology, and Nutrition (ISPGHAN)
|
Lal, Bikrant Bihari
|
|
|
18 |
5 |
p. 1343-1381
|
artikel
|
| 7 |
Dose–response relationship between serum N-glycan markers and liver fibrosis in chronic hepatitis B
|
Zhang, Chi
|
|
|
18 |
5 |
p. 1434-1447
|
artikel
|
| 8 |
Effect of diabetes on mortality and liver transplantation in alcoholic liver cirrhotic patients with acute decompensation
|
Lim, Jihye
|
|
|
18 |
5 |
p. 1579-1588
|
artikel
|
| 9 |
Hepatic arterial infusion chemotherapy plus camrelizumab and apatinib for advanced hepatocellular carcinoma
|
Zuo, Mengxuan
|
|
|
18 |
5 |
p. 1486-1498
|
artikel
|
| 10 |
Immunosuppression in adult liver transplant recipients: a 2024 update from the Italian Liver Transplant Working Group
|
Manzia, Tommaso Maria
|
|
|
18 |
5 |
p. 1416-1430
|
artikel
|
| 11 |
Impact of CT-relevant skeletal muscle parameters on post-liver transplantation survival in patients with hepatocellular carcinoma
|
Li, Zhaoxian
|
|
|
18 |
5 |
p. 1516-1527
|
artikel
|
| 12 |
Liver and cardiovascular outcomes in lean non-alcoholic fatty liver disease: an updated systematic review and meta-analysis of about 1 million individuals
|
Souza, Matheus
|
|
|
18 |
5 |
p. 1396-1415
|
artikel
|
| 13 |
Liver fibrosis is closely linked with metabolic-associated diseases in patients with autoimmune hepatitis
|
Liu, Kehui
|
|
|
18 |
5 |
p. 1528-1539
|
artikel
|
| 14 |
Reconsiderations for the liver donation from a living donor: addressing hepatic steatosis with weight loss preconditioning
|
Imamura, Hiroshi
|
|
|
18 |
5 |
p. 1382-1384
|
artikel
|
| 15 |
Regarding the role of post-transplant inflammatory cytokine signature on predicting tumor recurrence after liver transplantation for hepatocellular carcinoma
|
Chen, Bing
|
|
|
18 |
5 |
p. 1591
|
artikel
|
| 16 |
Reply to: “Is the TAE score a promising prognostic predictor for unresectable hepatocellular carcinoma treated with TACE plus lenvatinib with PD‑1 inhibitors? Further validation should be performed”
|
Zeng, Zhen-Xin
|
|
|
18 |
5 |
p. 1589-1590
|
artikel
|
| 17 |
Risk of hepatocellular carcinoma occurrence after antiviral therapy for patients with chronic hepatitis C Infection: a systematic review and meta-analysis
|
Lv, Gui-Ji
|
|
|
18 |
5 |
p. 1459-1471
|
artikel
|
| 18 |
Safety of right liver donation after improving steatosis through weight loss in living donors: a retrospective study
|
Yoon, Young-In
|
|
|
18 |
5 |
p. 1566-1578
|
artikel
|
| 19 |
Telomere length and mortality in lean MAFLD: the other face of metabolic adaptation
|
Alarabi, Mohammad
|
|
|
18 |
5 |
p. 1448-1458
|
artikel
|
| 20 |
The impact of artificial liver support system on intestinal microbiota and serum bile acid profiles in patients with acute-on-chronic liver failure: a prospective cohort study
|
Zeng, Yuyu
|
|
|
18 |
5 |
p. 1540-1554
|
artikel
|
| 21 |
The relationship between CXCR6+CD8+T cells and clinicopathological parameters in patients with primary biliary cholangitis
|
Shi, Huilian
|
|
|
18 |
5 |
p. 1555-1565
|
artikel
|
Tijdschrift beschrijving